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ABSTRACT 
Reduction of Estrogenic Bioactivity in Wastewater Through Electron Beam Irradiation.  
(May 2015) 
 
Rachel Komorek 
Department of Nutrition and Food Science 
Texas A&M University 
 
Emma Link 
Department of Nutrition and Food Science 
Texas A&M University 
 
Research Advisor: Dr. Suresh D. Pillai 
Department of Poultry Science 
 
Clean water availability has been made scarce by droughts in Texas caused by longer and hotter 
summers. Therefore, adopting new water reuse strategies has become important. A concern with 
recycled water has been the increase of emerging contaminants such as pharmaceuticals and 
chemicals, specifically estrogenic compounds, due to industrialization. Over exposure to 
exogenous estrogenic compounds has been shown to lead to cancers and diseases such as 
reproductive disorders. These adverse health effects can occur in humans and animals when  
estrogens are not effectively removed from wastewater effluent during water reclamation 
processes. Electron beam (eBeam) irradiation is an environmentally friendly technology that 
utilizes high energy electrons to yield rapid reduction and oxidation reactions, and has been 
shown to break down estrogens in wastewater biosolids. Our hypothesis is that estrogenic 
compounds, estrone (E1), 17-β-estradiol (E2), and bisphenol A (BPA), can be effectively broken 
down in wastewater effluent using eBeam irradiation. Should the estrogens be broken down, they 
will no longer be bioactive and capable of causing adverse health effects. The reduction in 
bioactivity of the estrogen was quantified using a yeast estrogen screening assay (YES assay) 
after eBeam irradiation of wastewater effluent at doses between 2 kGy and 15 kGy. The 
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detection limits of the YES Assay were 25pM for E1 and E2 and 0.25pM for BPA. Reduction 
was seen in E2 at an absorbed dose of 15kGy. However, reproducible reduction of estrogenic 
bioactivity for E1 and BPA could not be determined from irradiation trials. The YES Assay was 
originally developed with E2 and therefore it is possible that it is not an optimal assay to detect 
reduction in bioactivity for E1 and BPA. Overall we are not able to conclude that eBeam 
irradiation is an effective reduction method for the estrogens in wastewater effluent, and further 
studies are needed to confirm our hypothesis.   
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NOMENCLATURE 
 
BPA   Bisphenol A 
CPRG    Chlorophenol red-β-D-galactopyranoside; chromogenic substrate 
CSTX   Carter’s Creek Wastewater Treatment Facility 
DMSO   Dimethyl sulfoxide 
E1    Estrone 
E2    17-β-Estradiol 
eBeam   Electron beam  
EDC   Endocrine disrupting chemical  
TAMU  Texas A&M University Wastewater Treatment Facility 
UV   Ultra violet 
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CHAPTER I 
INTRODUCTION 
 
Importance of Effective Wastewater Reuse 
Water is a vital resource that is a basic human necessity; however, it is becoming scarce. A 
leading cause for this scarcity is the persistence of droughts across the United States. Between 
March 2014 and March 2015 the percentage of D4, the most extreme drought classification, has 
nearly doubled within the continental United States [1]. In particular, within the same timeframe, 
99% of California was in a state of drought. Currently, all across the United States, water 
restrictions are in effect. These restrictions prohibit the excessive use of clean water for the 
purposes of watering lawns, dishwashing in restaurants, and multiple other uses [2]. For 
example, in many cities, watering lawns is only allowed once a week between 7am – 11am and 
7pm – 11pm [2]. These city-wide restrictions are in effect due to the low amounts of water 
available in local aquifers, which are the main source utilized for city water supplies.  
 
Water supplies could potentially be supplemented with treated water from wastewater treatment 
facilities. Instead, this water is released directly into the environment, which is then termed 
effluent. Before the effluent could be considered safe for the public and used to supplement 
water supplies, it would need a secondary treatment process prior to entering a conventional 
drinking water treatment facility. Secondary treatment processes are needed due to the 
speculation that unsafe compounds remain in the effluent, demonstrated by negative 
environmental impacts such as those observed in fish and alligator populations [3]. The 
introduction of these compounds, called emerging contaminants, has increased with 
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industrialization. Emerging contaminants of concern in effluent include pharmaceuticals and 
chemicals, specifically estrogenic compounds [4]. Due to this increase in contaminants, it has 
become of great importance to discover new ways to enhance current water reclamation 
technologies [5].   
 
Current water reclamation technologies utilized in a water reclamation facility include membrane 
filtration, ultra violet (UV) light radiation, and oxidative chemicals. Membrane filtration utilizes 
various pore-size membranes, ranging from 0.001µm to 1.0µm. These filters are capable of 
removing pesticides, metal ions, salt, viruses, pathogenic bacteria, and other harmful 
contaminants [6]. UV light employs radiation to attack cell walls, making them unable to 
reproduce. In Japan, these methods have been used to reclaim water such that biodiversity and 
fish populations were restored within rivers [6]. Oxidative chemicals, such as chlorine dioxide 
and ferrate, are employed to control microbiological growth. This technology is most commonly 
used and is inexpensive; however, its effectiveness is limited by the turbidity of the water [6]. 
Therefore, it is necessary to use this method in conjunction with other reuse technologies such as 
electron beam (eBeam). The implementation of such technologies in a water reclamation facility 
could help to improve the reclamation process and increase water availability.  
 
eBeam as an Enhancement for Current Decontamination Methods 
eBeam irradiation utilizes high energy electrons, which travel at 99.99999% the speed of light 
[7]. These electrons have the capability to produce free radicals from water, which attack 
contaminants and can render them harmless through rapid reduction and oxidation reactions [8]. 
Currently, eBeam technology is used for the sterilization of medical devices, phytosanitation, 
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and food pasteurization [9]. The United States Environmental Protection Agency has approved 
the use of eBeam as a wastewater treatment technology for biosolids [10].  
 
In previous studies, eBeam irradiation has been shown to decrease the amount of estrogenic 
bioactivity and pathogenic contaminants in biosolids [11, 12]. Additionally, in our lab, it has 
been proven that eBeam irradiation had an increased reduction of estrogenic compounds when 
paired with other reducing technologies such as chlorine dioxide and ferrate. This synergistic 
effect allows decreased use of current treatments to receive the same or greater reduction in 
contaminants as compared to the use of only one treatment [11].  
 
 
 
 
 
 
 
 
 
 
 
Therefore, less chemical supplementation and lower doses of irradiation would be required to 
decontaminant wastewater effectively. Furthermore, this would prevent the addition of excess 
decontamination chemicals such as chlorine to effluent which has been proven to lead to various 
Figure 1: Diagram describing a potential modality of electron beam integration 
into a water reclamation facility. Adapted from an image in the article “Treat 
Water Right” in the Daily Star [13]. 
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diseases such as stomach discomfort, anemia, eye irritation, and nervous system effects [13].  
Figure 1 shows a potential modality to incorporate eBeam technology into a water reclamation 
facility. With the addition of eBeam technology in a water reclamation facility, a greater 
reduction of contaminants can be achieved using lower amounts of treatment. Therefore, eBeam 
irradiation could increase the efficiency of water reuse while safeguarding against emerging 
contaminants; thus proving to be a solution to the scarcity of water caused by droughts and 
industrialization. 
 
Issues with Estrogenic Compounds in Effluent 
Of many possible contaminants, estrogenic compounds can be noted as especially harmful in 
excessive amounts.	  Estrogens naturally produced by the human body include estrone (E1) and 
17-β-estradiol (E2). In the environment, estrogenic bioactivity can also be found in a variety of 
chemical structures that usually aren’t predicted to display such activity, predominantly known 
as xenoestrogens [14].	   Xenoestrogens have the capability of binding to the human estrogen 
receptor without having the characteristic estrogenic structure. Bisphenol A (BPA) is a 
xenoestrogen found most commonly in plastics as well as in pesticides [3]. Estrogenic 
compounds have been proven to act as endocrine disrupting chemicals (EDCs). EDCs are 
defined as chemicals that affect the developmental, reproductive, neurological, and immune 
functions in humans and wildlife [15]. EDCs have the capability to bind to multiple receptors 
found in the human body. These receptors include, but are not limited to, nuclear receptors, 
nonnuclear steroid hormone receptors, nonsteroidal receptors, orphan receptors, and the estrogen 
receptor [16]. When an EDC binds to a receptor within the human body it blocks the endogenous 
hormone from binding. By preventing the native hormone from binding, cell signals are blocked 
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and the body fails to respond properly [15]. EDCs have been linked to reproductive disorders 
such as early puberty, male infertility, abnormalities in male reproductive organs, and female 
reproductive diseases; it has also been suggested that EDCs cause breast cancer, uterine cancer, 
testicular cancer, and thyroid cancer [17]. 
 
Yeast Estrogen Screening Assay 
A method to measure estrogenic bioactivity is the yeast estrogen screening assay (YES Assay) 
developed by Routledge and Sumpter [14]. The YES Assay incorporates a recombinant yeast, 
Saccharomyces cerevisiae (S. cerevisiae), which was modified to have a human estrogen 
receptor (hER) encoded into its chromosome. With this hER, the yeast is capable of expressing 
the lac-Z gene in the presence of estrogenic compounds. The lac-Z-gene produces β-
galactosidase that metabolizes chlorophenol red-β-D-galactopyranoside (CPRG), a chromogenic 
substrate, resulting in a color change from yellow to red [14]. The amount of color change is 
directly related to the concentration of bioactive estrogenic compounds present in the solution. 
Therefore, using spectrophotometry, the concentration of bioactive estrogenic compounds can be 
quantified. Figure 2 demonstrates the reaction of the human estrogen receptor (hER) integrated 
in the genome of S. cerevisiae while in the presence of estrogenic compounds.  
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Figure 2. Yeast Cell with Integrated Human Estrogen Receptor. 1: Human 
estrogen receptor (hER) integrated in the nucleus of S. cerevisiae. 2: Unbound hER.  
3: Activation of hER through binding of estrogen. 4: Expression of Lac-Z gene.          
5: Production of β-galactosidase. 6: CPRG color change from yellow to the red in the 
presence of β-galactosidase. Adapted from an image in the journal article “Estrogenic 
Activity of Surfactants and Some of Their Degradation Products Assessed Using a 
Recombinant Yeast Screen” by Routledge and Sumpter [14]. 
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CHAPTER II 
METHODS 
 
Preparation of Media and Reagents  
All glassware to be used was cleaned to remove estrogenic compounds. Initially, glassware was 
placed a 1% Alconox (Alconox Inc., White Plains, New York) bath consisting of 10g Alconox in 
1L deionized water for at least four hours. The glassware was then rinsed with deionized water 
and placed in a secondary DriContrad (Decon Laboratories Inc., King of Prussia, Pennsylvania) 
bath consisting of 7.4g DriContrad in 1L deionized water for four hours. The glassware was then 
rinsed and placed in an oven (Fischer Scientific Isotemp 500 Series, Waltham, Massachusetts) 
for four hours at 150 °C and then autoclaved (Steris Amsco Century SG – 120 ScientificGravity 
Sterilizer, Mentor, Ohio) at 121°C for 15 minutes.  
 
Any materials, unless specified otherwise, were purchased from Sigma, St. Louis, Missouri. 
Minimal media was prepared by adding 13.61g KH2PO4, 1.98g (NH4)2SO4, 4.2g KOH pellets, 
0.2g MgSO4, 1mL Fe2(SO4)3 solution (40mg Fe2(SO4)3 /50mL H2O), 50mg L-leucine, 50mg L-
histidine, 50mg adenine, 20mg L-arginine-HCl, 20mg L-methionine, 30mg L-tyrosine, 30mg L-
isoleucine, 30mg L-lysine-HCl, 25mg L-phenylalanine, 100mg L-glutamic acid, 150mg L-
valine, and 375mg L-serine to 1L of double-distilled water. The media was then filtered through 
a 0.22µm bottle filter (VWR, Radnor, Pennsylvania) and stored at room temperature. 
 
A 20% (w/v) glucose solution was prepared by adding 24g glucose to a final volume of 120mL 
deionized water and dispensed into 20mL aliquots. An L-aspartic acid solution was prepared by 
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adding 240mg L-aspartic acid into 60mL deionized water and dispensed into 20mL aliquots. 
Both the glucose solution and L-aspartic acid test tubes were then autoclaved at 121°C for 15 
minutes, then stored at room temperature. An L-threonine solution was prepared by adding 
720mg L-threonine into 30mL deionized water and dispensed into 10mL aliquots. The test tubes 
were then autoclaved at 121°C for 15 minutes, then stored at 4°C. A copper (II) sulfate solution 
was prepared by adding 49.94mg copper (II) sulfate into 10mL deionized water. The solution 
was then sterile filtered through a 0.2µm sterile syringe filter (VWR, Radnor, Pennsylvania) into 
two 5mL aliquots. A CPRG solution was prepared, as needed, by adding 20mg CPRG to 2mL 
deionized water and then sterile filtered through a 0.2µm sterile syringe filter.   
 
The vitamin solution was prepared by adding 8mg thiamine, 8mg pyridoxine, 8mg pantothenic 
acid, 40mg inositol, and 20mL of biotin solution (2mg biotin/100mL deionized H2O) to 180mL 
double-distilled water. The solution was then filter sterilized through 0.22µm pore size filters 
(VWR, Radnor, Pennsylvania) and 10mL aliquots were stored at 4°C in sterile glass bottles. 
 
S. cerevisiae growth plates were made by adding 1.5% bacto agar (BD, Sparks, Maryland) to 
minimal media (1.5g bacto agar/90mL minimal media) and then autoclaved at 121°C for 15 
minutes, and cooled in a water bath to approximately 50°C. Once cooled, 10mL glucose 
solution, 2.5mL L-aspartic acid solution, 1mL vitamin solution, 0.8mL L-threonine solution, and 
250µL copper (II) sulfate solution was added and mixed, then poured into the agar. Growth 
plates were immediately poured into petri dishes and stored at 4°C in the dark. 
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Growth medium was prepared as needed with 5mL glucose solution, 1.24mL L-aspartic acid 
solution, 0.5mL vitamin solution, 0.4mL L-threonine solution, 125µL Copper (II) sulfate 
solution and 45mL minimal medium.  
 
Estrogen 1mM stock solutions were made in dimethyl sulfoxide (DMSO) and stored away from 
light. Stock solutions were made of the natural estrogens estrone (0.0135g/50mL DMSO), 17-β-
estradiol (0.0136g/50mL DMSO), and the xenoestrogen bisphenol A (0.0114g/50mL DMSO). 
 
S. cerevisiae Growth 
To obtain a culture of the S. cerevisiae, a -80°F freezer stock vial was quickly thawed and 
streaked onto growth plates. These plates were then incubated for 48 hours at 32°C until colonies 
developed, and then stored at 4°C for up to one month.  
 
S. cerevisiae Growth Curves 
Growth curves were created by preparing fresh growth medium in a 100mL flask and inoculating 
with one colony forming unit (CFU) of yeast from the stored growth plates. The inoculated 
medium was then incubated in an orbital shaker set to 225rpm 32°C. The optical density at 
600nm (OD600) was taken at 2, 4, 6, 8, 10, 12, 24, 33, 49, and 58 hours after inoculation by 
pipetting 100µL of the inoculated medium into a sterile cuvette. This cuvette was then placed 
into the spectrophotometer (Eppendorf Biophotometer, Hamburg, Germany) that had been 
calibrated with the blank cuvette made with sterile, fresh growth media.  
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Determination of S. cerevisiae Concentration  
The CFU concentration of yeast was determined from serial dilutions after 24 hours of growth in 
fresh growth media inoculated with one CFU incubated at 32°C and 225rpm. After 24 hours of 
growth, the OD600 value was obtained spectrophotometrically. Then 10-fold serial dilutions 
were made in phosphate buffered saline (PBS) in a biological safety cabinet (Labconco Pulifier 
Class II Biosafety Cabinet, Kansas City, Missouri). Then 100µL of the dilutions from 10-4 to 10-8 
were plated onto growth plates. The plates were then incubated at 32°C for 48 hours or until 
colonies formed. After colonies formed, they were enumerated to determine the CFU/mL.  
 
YES Assay 
The YES assay began by inoculating fresh growth medium with one CFU of yeast and allowing 
it to incubate in the orbital shaker (Lab-Line Incubator Shaker, Tripunithura, India) at 32°C and 
225rpm until it reached log phase of growth at approximately 24 hours; which was confirmed by 
taking the OD600 and recorded. Then seeded assay medium was prepared by adding 0.5mL 
stock CPRG solution to fresh growth media and inoculating it with 2mL of the log phase growth 
medium. Ten-fold dilutions for E1, E2 and BPA or irradiated and extracted estrogens were 
prepared in a 96 well dilution plate (VWR, Radnor, Pennsylvania) in DMSO. Using a 
multichannel pipette (VWR, Radnor, Pennsylvania) 5µL of the appropriate dilutions were 
transferred into triplicate wells of another 96 well assay plate (Costar, Corning, New York) 
containing 195µL of the seeded assay medium. At least three wells containing only seeded assay 
medium and DMSO were used as negative controls. The plate was then mixed thoroughly with a 
multichannel pipette (Eppendorf, Hamburg, Germany). The lid of the well plate was carefully 
taped down such that there was no air flow or potential evaporation of the solutions. The assay 
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plate was then placed in an incubator (Fischer Scientific, Waltham, Massachusetts) at 32°C in the 
dark. Every 24 hours the assay plate was mixed to prevent settling of the yeast. Once the DMSO 
negative controls began to change color from yellow to red, the assay plate was read immediately 
on a spectrophotometer at 535nm and the data was plotted absorbance versus estrogen 
concentration.  
 
Water Samples 
The test water samples were effluent samples collected from the Carter’s Creek Wastewater 
Treatment Facility (CSTX) and Texas A&M Wastewater Treatment Facility (TAMU) effluent. 
Samples were collected and stored at 4°C for a maximum of 48 hours. 
 
eBeam Irradiation  
The experiment was carried out in a Biosafety Level 2 lab with access to the National Center for 
Electron Beam Research (NCEBR) on the Texas A&M University campus. The effluent samples 
were spiked to make concentrations of 10-5M E1, 10-5M E2 and 10-4M BPA, and aliquoted to 
make individual pouches (sealed air-tight). One pouch of each effluent sample was left un-spiked 
and was used as the effluent control. Each pouch was then triple-packed according to biosafety 
level two (BSL2) procedures and transported to NCEBR to be irradiated. Spiked samples were 
irradiated using a 10MeV electron beam at target doses corresponding to 0, 2, 4, 8, 10, and 
15kGy. The un-spiked and un-irradiated (0kGy) effluent control samples were both transported 
to the NCEBR as well, but not irradiated.  
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eBeam irradiation doses were measured using internationally validated Alanine pellet dosimeters  
(Harwell Dosimeters, Oxfordshire, United Kingdom). The dosimeters (in heat-sealed pouches) 
were placed within the sample to insure correct absorbance of the eBeam irradiation dose and 
measured using the Bruker E-scan spectrometer (Bruker, Billerica, Massachusetts). Previous 
studies validated the pouch system used to insure effective irradiation with a dose-uniformity 
ratio (DUR) of approximately 1.0 [12]. 
 
Estrogen Extraction 
After eBeam irradiation, the pouches were aseptically cut open and poured into individual 15mL 
glass tubes, and the estrogens were extracted using 99% w/v ether (VWR, Radnor, Pennsylvania) 
in a fume hood (Kewaunee Scientific Engineering, Adrian, Michigan). To extract the estrogens, 
5mL of ether was added to each 1mL sample and vortexed (Fischer Scientific Vortex Mixer, 
Waltham, Massachusetts) to mix thoroughly. The tubes were placed in a dry ice bath for one 
minute to allow the aqueous phase to solidify. Once solidified, the organic phase (supernatant) 
was removed and transferred into new sterile, glass tubes. The tubes were left open in the fume 
hood, in the dark, until the ether evaporated. Estrogens were resuspended in 100µL of DMSO, 
and then vortexed. Samples were transferred into 1.5mL labeled sterile tubes and stored in the 
dark until processed in the YES Assay.  
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CHAPTER III 
RESULTS 
 
Growth Curve 
The results from each OD600 reading were graphed versus time (hours). The log phase was then 
determined from the graphs shown in Figure 3 from when the yeast was in the middle of 
exponential growth; between 15 and 25 hours.	  The log phase of growth had to be determined to 
know when to inoculate the seeded assay medium for the YES Assay. The growth curve was 
repeated once to insure accuracy in determining the log phase of yeast growth.	  
 
To determine the concentration of yeast cells during the log phase, an inoculated growth media 
was grown to log phase and the OD600 was taken. Two sets of a 10-fold serial dilution of the log 
phase growth media were made and the dilutions between 10-4 and 10-7 were plated on growth 
plates and counted. This indicated the CFU concentration corresponding to the OD600 recorded 
earlier. The concentration of yeast during log phase was calculated to be 7.18 x 106 ± 0.78 
CFU/mL. 
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Figure 3. S. cerevisiae Growth Curves A: Trial one of determining the log phase of 
S. cerevisiae. B: Trial two of determining log phase of S. cerevisiae.  
Log Phase 
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Detection Limit Determination 
The sensitivity of S. cerevisiae’s capability to bind to the estrogenic compounds and produce a 
color change was determined with the YES Assay. A range of dilutions from 10-5M to 10-12M for 
E1and E2, and from 10-3M to 10-10M for BPA, were plated following the YES Assay procedure 
and the resulting plate is shown in Figure 4. 
 
 
 
 
   
 
 
 
Figure 4. YES Assay Detection Limit Plate Black boxes indicate the detection limit 
range for each estrogen in the YES Assay. E1and E2 have detection limit ranges of 
25pM – 2500pM. BPA has a detection limit range of 0.25pM – 25pM. 
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Figure 5. Detection Limit Range of S. cerevisiae in YES Assay. A: Detection limit 
of E1 demonstrating detection limit range of 25pM – 2500pM. B: Detection limit of 
E2 demonstrating detection limit range of 25pM – 2500pM. C: Detection limit of BPA 
demonstrating detection limit range of 0.25pM – 25pM. Linear lines depict the 
detection limit range for the YES Assay for each estrogen tested. 
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Figure 5 demonstrates the detection limit of the yeast, S. cerevisiae, for each of the estrogens 
tested. The detection limit for E1 and E2 was 25pM, and for BPA the detection limit was 
0.25µM. These values represent the minimum concentration of estrogen required for the yeast to 
detect the presence of the estrogen in solution, as detected by a change in its absorbance at 
535nm. E1and E2 have detection limit ranges of 25pM – 2500pM. BPA has a detection limit 
range of 0.25pM – 25pM as shown with lines. 
 
Yeast Estrogen Screening Assay of Irradiated Samples 
Effluent from TAMU and CSTX were collected and spiked with estrogens. The variation of 
effluents ensured that a variety of wastewater treatment methods were represented in the 
experiment; this variation included the aerobic digestion method, which is utilized at TAMU, 
and the anaerobic digestion method, which is used at the CSTX. Samples were spiked with 
respective estrogens and irradiated at NCEBR with doses between 0kGy and 15kGy. The 
samples were processed for estrogen extraction according to methods, serially diluted in DMSO, 
and then plated in the 96-well assay plate according to the detection limits predetermined such 
that a reduction could be quantified in the YES Assay detection range. After incubation, the 
absorbance at 535nm versus irradiation dose was plotted. 
 
Trial 1 samples were incubated for 72 hours which was the amount of time required for DMSO 
control samples to display activity through color change. However, at this time point many of the 
estrogens were on the upper limits of the detection limit ranges. Also, the recovery of the 
samples from Trial 1 was variable due to the packaging method; the recovery ranged from 50% 
to 100% for each irradiated effluent sample.  Trial 2 data was collected at 48 hours to ensure 
22	  
	  
samples were detected in the middle of the ranges for each estrogen tested. Also, in Trial 2 the 
packaging method was optimized such that recovery was 100% for each sample.  
 
E1, shown in Figure 6, displayed no observable reduction in Trial 1 or Trial 2 for either effluent 
sample at any absorbed dose. E2, shown in Figure 7, displayed reduction at 15kGy in Trial 1 for 
both effluent samples. The reduction in the CSTX effluent was comparable to the unspiked 
effluent whereas in the TAMU effluent it was not. In Trial 1, the sample at 8kGy for TAMU 
effluent is not shown due to 100% loss in the extraction process. E2 in Trial 2 displayed 
reduction at absorbed doses between 2kGy and 15kGy for TAMU effluent samples, and between 
10kGy and 15kGy for CSTX effluent samples. However, the level of reduction was not 
comparable to the unspiked effluent. BPA, shown in Figure 8, in Trial 1 displayed reduction at 
absorbed doses between 2kGy and 15kGy for TAMU effluent samples, but the level of reduction 
was not comparable to the unspiked effluent. There was no observable reduction for BPA in 
CSTX effluent samples at any absorbed dose. BPA in Trial 2 displayed no significant reduction 
for either effluent sample at any absorbed dose. 
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Figure 6. E1 Spiked Effluent Samples (TAMU and CSTX) Irradiated at Various 
Absorbed Doses. A: Trial 1 incubated for 72 hours at 32°C. B: Trial 2 incubated for 
48 hours at 32°C.  
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Figure 7. E2 Spiked Effluent Samples (TAMU and CSTX) Irradiated at Various 
Absorbed Doses.. A: Trial 1 incubated for 72 hours at 32°C. Sample at 8kGy for 
TAMU effluent was lost in the extraction process. B: Trial 2 incubated for 48 hours at 
32°C.  
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Figure 8. BPA Spiked Effluent Samples (TAMU and CSTX) Irradiated at 
Various Absorbed Doses. A: Trial 1 incubated for 72 hours at 32°C. B: Trial 2 
incubated for 48 hours at 32°C.  
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CHAPTER IV 
CONCLUSION 
 
A significant reduction in Trial 1 was seen in E2 at 15kGy for both TAMU and CSTX effluents. 
Specifically, there was an 82.3% reduction in TAMU effluent from 0kGy to 15kGy, and a 43.8% 
reduction in CSTX effluent from 0kGy to 15kGy. However, a majority of errors in the assay 
occurred in Trial 1 and these errors can be attributed to the efficiency of the extraction method. 
In Trial 1, sample recovery ranged from 50% to 100% across all samples. The inconsistent loss 
of samples in Trial 1 created results that demonstrated no logical trend, including the control 
sample for E1 spiked TAMU effluent at 0kGy which contained less estrogenic bioactivity than 
that of the sample irradiated at 15kGy. Therefore, indicating unreliability of the results in Trial 1.  
 
In Trial 2, after extraction process optimization, recovery was close to 100% for all samples, and 
the results were determined to be more reliable. There was not a reduction observed for E1 
spiked TAMU effluent, but instead a 16.7% increase in bioactivity between 0kGy spiked TAMU 
effluent and 15kGy spiked TAMU effluent. However, E1 spiked CSTX effluent demonstrated a 
24.0% reduction in bioactivity within the same parameters. E2 demonstrated the greatest 
reduction in bioactivity between 0kGy spiked effluents and 15kGy spiked effluents. The percent 
reduction between these samples included 52.3% for TAMU and 43.0% for CSTX. BPA also 
demonstrated an overall reduction between 0kGy spiked effluents and 15kGy spiked effluents; 
however, this percentage only included a 15.5% reduction for TAMU and 4.37% for CSTX.  
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While overall decreases were observed between 0kGy spiked effluents and 15kGy spiked 
effluents in Trial 2, a bell curve trend occurred in most all trials. This bell curve demonstrates an 
increase in estrogenic bioactivity between 2kGy spiked effluents and 8kGy spiked effluents. Due 
to the occurrence of this trend, it is possible to infer that lower doses (2kGy-8kGy) of eBeam 
irradiation, when in contact with estrogenic compounds, creates by-products that are more 
bioactive; thus showing an increase in estrogenic bioactivity.   
 
When compared to the reduction found in E2, the lower amount of reduction in E1 and BPA can 
be attributed to the basis that the YES Assay was originally designed for E2 detection [14]. 
Additionally, E2 has been shown to have up to five times more binding capability than E1 [18]. 
Also, from results shown in detection limit trials for BPA, it required significantly higher 
concentrations to display similar bioactivity when compared to the natural estrogens E1 and E2.  
Therefore, the YES Assay may not be an effective method to quantify the change in bioactivity 
for E1 and BPA.  
 
To prove our hypothesis and quantify reduction of estrogenic bioactivity after eBeam irradiation 
in effluent, an alternative method of estrogenic bioactivity detection is required. In our lab, the 
use of the breast cancer cell line, ZR-75, has effectively quantified a reduction in estrogenic 
bioactivity in biosolids. Therefore, the ZR-75 is a potentially more effective assay to detect 
reduction of estrogenic bioactivity than the YES Assay. 
 
Although eBeam as a single technology was not definitively proven to be efficient in reducing 
bioactivity of all estrogenic compounds, synergy with other reclamation technologies is still a 
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possibility. Our lab has shown that eBeam irradiation has participated in synergistic reactions 
with oxidative chemicals, effectively reducing bioactivity of estrogenic compounds in biosolids 
[11]. Therefore, trials with eBeam irradiation coupled with oxidative chemicals may be able to 
reduce the bioactivity of estrogenic compounds to undetectable amounts in effluent.  
 
At this time, more trials are required with the YES Assay to definitively prove the effectiveness 
of eBeam irradiation as a method for reclaiming effluent water for reuse. If the reduction 
between 0kGy and 15kGy can be more precisely quantified, eBeam irradiation could increase the 
efficiency of water reuse while safeguarding against emerging contaminants; thus proving to be a 
solution to the scarcity of water caused by droughts and industrialization.   
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